Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page
- Check4 days agoChange DetectedA new revision label v3.5.5 is added to the record history, replacing the previous v3.5.4 label to reflect a page update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the Record History, and the previous 'Revision: v3.5.3' entry was removed from the list.SummaryDifference0.1%

- Check47 days agoChange DetectedA minor interface/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a change to the page’s release/versioning rather than any study-record details.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision (v3.5.0) was added to the record history, and an older revision (v3.4.3) was removed. This is a metadata/version-history change rather than an update to trial content.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.